NASDAQ:EIGR Shareholder Notice: Lawsuit Alleges Misleading Statements by Eiger BioPharmaceuticals, Inc.
An investor, who purchased shares of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR), filed a lawsuit against Eiger BioPharmaceuticals, Inc over alleged violations of Federal Securities Laws.
View full press release